UBS cuts Eurozone equities on growing risks to economic growth

UBS’s Chief Investment Office downgraded Eurozone equities to “neutral,” cutting its 2026 earnings growth forecast to 5% from 7% as energy flow disruptions threaten to derail a regional manufacturing recovery.

The Swiss bank’s wealth management arm said the longer energy disruptions persist, the greater the risk to the global economy, adding that Eurozone equities are pro-cyclical and sensitive to elevated oil and gas prices. It simultaneously upgraded Swiss equities and European health care to Attractive.

The Euro Stoxx 50 stood at 5,569 on March 24. UBS set a June 2026 target of 6,000 and a December 2026 target of 6,300.

UBS had previously favored the region on three grounds: an improving cyclical outlook, a better structural backdrop and reasonable valuations.

It said valuations remain reasonable at 14.1 times forward price-to-earnings, a 7% premium to the 15-year average, but growing risks to the cyclical recovery drove the rating change.

“The longer disruptions to energy flows persist, the greater the risk to the global economy, and Eurozone equities are pro-cyclical and sensitive to elevated oil and gas prices, which could undermine the manufacturing recovery we were expecting,” the brokerage said.

In a worst-case scenario where disruptions last around six months, the bank warned earnings growth could stagnate in 2026 for a fourth consecutive year. It maintained its 18% profit growth assumption for 2027.

UBS said the current energy shock differs from the 2022 post-Russia-Ukraine surge, when central banks were tightening aggressively and markets had priced in the permanent loss of Russian gas supply, then 35% to 40% of EU consumption.

Middle Eastern supply, by contrast, accounts for only 4% of EU gas consumption and is expected to return. The bank said it expects central banks to treat the current disruption as transitory.

Both Swiss equities and European health care have fallen more than 10% since the start of the conflict. UBS cited dividend yields of 3.2% for Switzerland and 2.7% for European health care as sources of return stability.

The brokerage retained preferences for Germany, European IT, industrials and real estate within the region.

In an upside scenario, UBS set a December 2026 Euro Stoxx 50 target of 7,100. Its downside target stands at 4,400, tied to risks including extended energy disruption, AI investment disappointment and a re-escalation of US-EU trade tensions.